Overview
Biology has become an information science, with an increasing capacity to generate data of great relevance to human disease. An important example is The Cancer Genome Atlas (TCGA) [1] , which generates data on well-characterized oncology samples and provides a public portal for linking gene mutation and regulation to cancer therapies and outcomes. These types of well-characterized data sets provide an opportunity for researchers from many fields to contribute new ideas for computational analysis.
One theme represented in the 2013 Proceedings is analysis of such public data sets by algorithms known from computer science but less often applied in computational biology and bioinformatics. Previous types of algorithms have included support vector machines [2] , graph diffusion [3, 4, 5] , and Steiner trees [6, 7] . Algorithms represented this year include set cover (Przytycka and coworkers), color-coded paths (Kahveci and coworkers), and regularized regression (Gevart and Plevritis).
A second theme is using known biological networks and pathways to organize calculations. Perhaps the most prevalent example is Gene Set Enrichment Analysis (GSEA) [8] . Lussier and co-workers describe extensions of GSEA to data sets from individuals rather than groups, and Ritchie and coworkers use interactions to organize analysis of interaction terms in genome-wide association studies (GWAS).
New algorithms from computer science
Przytycka and coworkers extend a set-cover algorithm from genes [9] to modules. These cover algorithms work on bipartite graphs, here with one set of vertices representing disease cases, a second set of vertices representing features (genes or gene modules), and edges indicating that the gene or module is dysregulated in a specific disease case. The k-cover optimization problem is to identify the smallest number of features so that each case has edges to at least k features. The authors generalize this NP-hard problem by also assigning a cost for each module that is reduced when the genes within the module have concordant expression regulation. A fast, greedy forward selection adds modules incrementally, either from a pre-calculated set or by defining modules on the fly. The method is effective in recovering known subtypes of glioblastoma multiforme. This type of approach, based on support, recalls approaches such as the Apriori algorithm for itemset mining [10] and the Teiresias algorithm for pattern discovery [11] .
Kahveci and coworkers investigate an algorithm to identify signaling pathways of defined length. For a pathway desired to have m steps, a possible algorithm explored is to color each vertex one of m colors, and then to search for paths that include one vertex of each color. It remains to be seen whether this method is competitive with other related approaches, such as prize-collecting Steiner trees [7] and flow-based methods [12] that have fast, optimal solvers. The restriction to length m paths is motivated by a requirement that signaling pathways include a membrane-bound receptor, cytoplasmic signaling proteins, and nuclear transcription factors; constraints based on this biology and directed interactions may also perform better than path length restrictions.
Gevart and Plevritis also describe methods motivated by TCGA data. This approach generally follows successful methods introduced by others that use genetic and epigenetic features (copy number variation, methylation) to suggest driver genes, and then build out downstream pathways using regularized regression [13, 14] or other network-based association tests [15] . While predictions of expression perform better than random for an ovarian cancer data set, the top drivers predicted for a gliobastoma multiforme data set perform no better than a random collection. These results point to the uncertainty of applying established algorithms to new data sets and the importance of randomization tests for unbiased assessment of performance.
Pathways as a guide to analysis
Lussier and coworkers investigate personalized RNA-seq data by generalizing a singlesample method they developed for microarray data [16] . The main idea is to generate pathway scores by comparing expression levels between pathway and non-pathway genes. The authors find that converting raw expression values to ranks improves performance for many tasks. While the method is assessed to be feasible, traditional analysis of sample groups still appears to out-perform single-sample analysis.
Ritchie and coworkers investigate interaction terms in genome-wide association studies. Gene-environment interactions are already addressed by conventional methods, but gene-gene interactions are more challenging for both computational and statistical reasons. Computing all gene-gene interactions, or more accurately SNP-SNP interactions, incurs a large computational cost. Furthermore, the large number of tests requires an interaction term to be large for adequate power. The method proposed by Ritchie and coworkers, and also explored by others previously, is to restrict tests to SNPs to pairs in genes that have prior evidence for participating in a shared biological process or pathway. The threshold for evidence is increased until the candidate pairs are reduced to an acceptably small number, for example equivalent to the number of single-SNP tests. One challenge with including interaction terms is that tests for marginal effects may actually have greater power even when the interaction term is non-zero. For example, dominant and recessive genetic models are equivalent to interaction terms at a single locus, and a one degree-of-freedom test of a linear model for phenotype versus allele dose can have greater power than a two degree-of-freedom test that includes the interaction term. In an application to a cataract phenotype, the authors test 57,376 two-SNP models, requiring a p-value of 8.7 × 10 −7 for genome-wide significance. The best p-value is 3.4×10 −6 , however, typical of other searches for that have failed to identify interactions with statistical significance. While it may be feasible to identify interaction terms with greater power from larger population sizes, the lack of significance sets an upper limit on the magnitude of interaction terms and hence a possible limit on the biological relevance. Furthermore, it remains unclear whether genes identified through interaction terms would have been missed by conventional marginal tests on individual SNPs.
Future perspective
The contributions to this Proceedings consider two types of network models: on the one hand pre-calculated modules or curated pathways, on the other modules or pathways discovered from biological data. An important future direction may be module searches that use high-throughput data but are biased by existing network models. Generative models, such as stochastic block models, may provide an appropriate framework for network analysis biased by empirical knowledge. These models have received increasing attention for both static module discovery and dynamic network evolution [17, 18, 19, 20] .
A critical limitation of network biology is the limited amount of high-quality network data. High-throughput protein-protein interaction data sets are available for human [21] but are incomplete [22, 23, 24] . Interactions between transcription factors to regulated genes provide crucial links between protein signaling and gene regulation, but are even less well mapped for human. Experimental progress here could result in dramatic gains for computational methods that already exist but which have been limited by lack of data.
